Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Explorative, Double-blind, Double-dummy, Multi-center, Parallel Group Study to Assess Sustainable Efficacy of Once Daily Vardenafil (10 mg) for 12 and 24 Weeks Versus Vardenafil PRN in Men With Mild or Mild to Moderate ED

NCT00786253 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00786253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00786253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Explorative, Double-blind, Double-dummy, Multi-center, Parallel Group Study to Assess Sustainable Efficacy of Once Daily Vardenafil (10 mg) for 12 and 24 Weeks Versus Vardenafil PRN in Men With Mild or Mild to Moderate ED
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2005
Completion date
January 31, 2007
Enrollment
236 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction